Logo image of PCN

PIMCO CORPORATE & INCOME STR (PCN) Stock Price, Quote, News and Overview

NYSE:PCN - New York Stock Exchange, Inc. - US72200U1007 - Currency: USD

12.65  -0.02 (-0.16%)

Fundamental Rating

2

Overall PCN gets a fundamental rating of 2 out of 10. We evaluated PCN against 0 industry peers in the Unkown industry. PCN has a bad profitability rating. Also its financial health evaluation is rather negative. PCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PCN was profitable.
In the past year PCN had a positive cash flow from operations.
PCN had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PCN reported negative operating cash flow in multiple years.
PCN Yearly Net Income VS EBIT VS OCF VS FCFPCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA 9.47%
ROE 11.56%
ROIC 5.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCN Yearly ROA, ROE, ROICPCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

PCN's Profit Margin has improved in the last couple of years.
PCN's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of PCN has declined.
Industry RankSector Rank
OM 80.6%
PM (TTM) 107.46%
GM 79.1%
OM growth 3Y-2.08%
OM growth 5Y-1.16%
PM growth 3YN/A
PM growth 5Y10.3%
GM growth 3Y-2.8%
GM growth 5Y-1.61%
PCN Yearly Profit, Operating, Gross MarginsPCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150 200

More info and screens

2

2. Health

2.1 Basic Checks

PCN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PCN Yearly Shares OutstandingPCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
PCN Yearly Total Debt VS Total AssetsPCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

PCN has an Altman-Z score of 3.40. This indicates that PCN is financially healthy and has little risk of bankruptcy at the moment.
PCN has a debt to FCF ratio of 2.90. This is a good value and a sign of high solvency as PCN would need 2.90 years to pay back of all of its debts.
A Debt/Equity ratio of 0.20 indicates that PCN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.9
Altman-Z 3.4
ROIC/WACCN/A
WACCN/A
PCN Yearly LT Debt VS Equity VS FCFPCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.16 indicates that PCN may have some problems paying its short term obligations.
PCN has a Quick Ratio of 0.16. This is a bad value and indicates that PCN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
PCN Yearly Current Assets VS Current LiabilitesPCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

PCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.15%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.15% on average over the past years.
The Revenue has decreased by -2.13% in the past year.
Measured over the past years, PCN shows a small growth in Revenue. The Revenue has been growing by 3.95% on average per year.
EPS 1Y (TTM)51.15%
EPS 3YN/A
EPS 5Y6.15%
EPS Q2Q%-2.02%
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y3.31%
Revenue growth 5Y3.95%
Sales Q2Q%34.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCN Yearly Revenue VS EstimatesPCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.20, the valuation of PCN can be described as reasonable.
When comparing the Price/Earnings ratio of PCN to the average of the S&P500 Index (26.92), we can say PCN is valued rather cheaply.
Industry RankSector Rank
PE 10.2
Fwd PE N/A
PCN Price Earnings VS Forward Price EarningsPCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.27
EV/EBITDA N/A
PCN Per share dataPCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.66
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.78%, PCN is a good candidate for dividend investing.
PCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 9.78%

5.2 History

The dividend of PCN has a limited annual growth rate of 0.99%.
PCN has been paying a dividend for at least 10 years, so it has a reliable track record.
PCN has decreased its dividend recently.
Dividend Growth(5Y)0.99%
Div Incr Years0
Div Non Decr Years1
PCN Yearly Dividends per sharePCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

95.83% of the earnings are spent on dividend by PCN. This is not a sustainable payout ratio.
PCN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP95.83%
EPS Next 2YN/A
EPS Next 3YN/A
PCN Yearly Income VS Free CF VS DividendPCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
PCN Dividend Payout.PCN Dividend Payout, showing the Payout Ratio.PCN Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO CORPORATE & INCOME STR

NYSE:PCN (6/27/2025, 8:04:00 PM)

12.65

-0.02 (-0.16%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-03 2025-03-03
Earnings (Next)09-22 2025-09-22
Inst Owners15.9%
Inst Owner Change3.83%
Ins OwnersN/A
Ins Owner Change0%
Market Cap809.35M
Analysts0
Price TargetN/A
Short Float %0.04%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 9.78%
Yearly Dividend1.34
Dividend Growth(5Y)0.99%
DP95.83%
Div Incr Years0
Div Non Decr Years1
Ex-Date06-12 2025-06-12 (0.1125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.2
Fwd PE N/A
P/S 12.08
P/FCF 19.27
P/OCF 19.27
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)1.24
EY9.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.66
FCFY5.19%
OCF(TTM)0.66
OCFY5.19%
SpS1.05
BVpS9.74
TBVpS9.74
PEG (NY)N/A
PEG (5Y)1.66
Profitability
Industry RankSector Rank
ROA 9.47%
ROE 11.56%
ROCE 8.58%
ROIC 5.68%
ROICexc 5.68%
ROICexgc 5.85%
OM 80.6%
PM (TTM) 107.46%
GM 79.1%
FCFM 62.69%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y-1.16%
PM growth 3YN/A
PM growth 5Y10.3%
GM growth 3Y-2.8%
GM growth 5Y-1.61%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.9
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 58.33%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.4
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.15%
EPS 3YN/A
EPS 5Y6.15%
EPS Q2Q%-2.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.13%
Revenue growth 3Y3.31%
Revenue growth 5Y3.95%
Sales Q2Q%34.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.92%
EBIT growth 3Y1.16%
EBIT growth 5Y2.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.78%
OCF growth 3YN/A
OCF growth 5YN/A